REQUEST A DEMO
Total
USD $0.00
Search more companies

Mw - Pharma Sp. z o.o. (Poland)

Main Activities: Department Stores
Secondary Activities: Pharmaceutical Preparation Manufacturing | Pharmacies and Drug Stores | Cosmetics, Beauty Supplies, and Perfume Stores
Full name: Mw - Pharma Sp. z o.o. Profile Updated: March 27, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Polish Download a sample report

Mw - Pharma Sp. z o.o. is based in Poland, with the head office in Kalisz. The company operates in the Department Stores sector. The company was established on April 27, 2010. The total number of employees is currently 101 - 250 (2013). There was a net sales revenue increase of 14.08% reported in Mw - Pharma Sp. z o.o.’s latest financial highlights for 2024. Its total assets grew by 19.13% over the same period. The enterprise’s net profit margin increased by 1.08% in 2024.

Headquarters
Ul. Polna 14
Kalisz; Wielkopolskie; Postal Code: 62-800

Contact Details: Purchase the Mw - Pharma Sp. z o.o. report to view the information.

Basic Information
Total Employees:
Purchase the Mw - Pharma Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Mw - Pharma Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Mw - Pharma Sp. z o.o. report to view the information.
Incorporation Date:
April 27, 2010
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
94%
Company Performance
Financial values in the chart are available after Mw - Pharma Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
14.08%
Total operating revenue
14.09%
Operating profit (EBIT)
54.33%
EBITDA
49.84%
Net Profit (Loss) for the Period
55.69%
Total Assets
19.13%
Total Equity
42.27%
Operating Profit Margin (ROS)
1.27%
Net Profit Margin
1.08%
Return on Equity (ROE)
2.56%
Debt/Equity
-0.13%
Quick Ratio
0.28%
Cash Ratio
0.3%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?